Loading organizations...
Loading organizations...
Biopharmaceutical company developing therapeutic antibodies for diseases.
Kanova has raised $16.6M across 1 funding round.
Kanova has raised $16.6M in total across 1 funding round.
Kanova has raised $16.6M in total across 1 funding round.
Kanova's investors include bioVENTURE, Kington Capital, Northern Light Venture Capital.
Kanova has raised $16.6M across 1 funding round. Most recently, it raised $16.6M Series A in November 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 26, 2018 | $16.6M Series A | bioVENTURE, Kington Capital, Northern Light Venture Capital |